Diagnostic Use
Lipid testing is mostly performed to inform cardiovascular risk but can also be useful to determine the cause of acute pancreatitis and several metabolic conditions.
The lipid profile includes the following tests:
- Triglycerides
- Total cholesterol
- HDL cholesterol
- LDL cholesterol (calculated)
- Non-HDL cholesterol (calculated)
- Total/HDL ratio (calculated)
See ‘Specimen’ section of pre-testing requirements above for more information on fasted vs. non-fasted sampling.
Triglycerides – In healthy people triglycerides rise about 15-20%, or about 0.2-0.3 mmol/L (2,4), after a meal (for up to 6-8h)(1). Some patients have slow lipid particle clearance after food (so-called ‘post-prandial dyslipidaemia’). They typically have a high triglyceride and low HDL pattern even on fasting samples. However, non-fasting triglycerides may even better predictive value for future CVD events in such patients (9,10). Therefore an initial non-fasting sample is also reasonable. The disadvantage is that accurate ranges are less well documented than for fasting measurements, but non-fasting triglycerides above 2 mmol/L is suspicious for such ‘postprandial dyslipidaemia’ unless explained by some other factor, such as alcohol or oestrogens(11).
LDL-cholesterol calculation – In most labs, including LabPLUS, LDL-cholesterol is calculated from other lipid measures (7, 8). There is more than one equation used to calculate LDL in public labs. In most patients, the formulae agree well, but diverge when triglycerides are high. (LabPLUS uses the Sampson equation, which allows calculation of LDL even when triglycerides are as high as 9.0 mmol/L.
Non-HDL cholesterol – The total of all atherogenic (apoB containing) particles can be expressed together as non-HDL cholesterol. This includes LDL as well as VLDL, IDL, and lipoprotein (a). Non-HDL compares favourably with LDL as a CVD risk marker, especially in patients with poor lipid particle clearance where the proportion of non-LDL particles in increase. It does not require the patient to be fasting. Non-HDL cholesterol can be easily calculated by the formula: Non-HDL cholesterol = total cholesterol – HDL cholesterol.
Although the modern emphasis is not on strict cholesterol treatment targets, but rather a risk-based approach, historically non-HDL treatment targets were usually about 0.8 mmol/L higher than LDL targets. In a non-fasting patient, a non-HDL level of 5.7 mmol/L or more may indicate genetic hypercholesterolemia that requires further evaluation or a secondary cause (13) .
Interpretation
Note that the intervals provided below are not the typical 95% or 99% intervals that represent the ‘normal’ population nor ideal ranges, but should indicate what is acceptable if there are no other major risk factors present. In a patient at high risk of CVD, a lower LDL than the intervals below may be preferable.
Reference Intervals
Adults
| total cholesterol |
<5.0 |
| HDL cholesterol |
>1.0 |
| LDL cholesterol |
<3.4 |
| Triglyceride (TG) |
<2.0 |
| total/HDL ratio |
<4.5 |
| Non-HDL cholesterol |
<4.2 |
References
Patients <19 years old
| Age |
Total cholesterol |
HDL cholesterol |
Triglyceride |
| 0 – 14 days |
1.2 – 3.2
|
0.4 – 1.1
|
0.9 – 3.0
|
| 15 days – 1 year |
1.6 – 6.2
|
0.3 – 1.9
|
0.6 – 3.0
|
| 1 to 19 years |
2.9 – 5.4
|
0.8 – 1.9
|
0.5 – 2.3
|
Units : mmol/L
Conversion factors :
Cholesterol (total, HDL and LDL): mg/100 mL x 0.026 = mmol/L
mmol/L x 38.6 = mg/100 mL
Triglyceride: mg/100 mL x 0.0113 = mmol/L
mmol/L x 88.5 = mg/100 mL
Test Method
Refer to individual tests.